Page Updated:
Obesity is a worldwide epidemic and in the United States alone, 60% of adults are obese or overweight.1 Those struggling with obesity are at a higher risk of developing cardiovascular disease, cancer, and diabetes.2 We’re proud to provide patients struggling with obesity in San Marcos, Menifee, Temecula and throughout San Diego County with non-surgical weight loss options. If you want to take action but aren’t ready to undergo, or aren’t a candidate for, surgical intervention, weight loss injections may be right for you.
- Weight Loss Injections
- What Is GLP-1?
- Benefits of GLP-1
- How Much Weight Will I Lose With Weight Loss Injections?
- GLP-1 Injection Treatment Tiers
- Does GLP-1 Have Any Side Effects?
- Candidates For GLP-1 Weight Loss Injections
Weight Loss Injections in San Marcos, Menifee, and Temecula
At Before-N-After, we understand that losing and keeping weight off doesn’t always come down to willpower. Multiple factors, such as genetics, diet, and exercise play into body mass. We’re proud to offer GLP-1 weight loss injections for individuals looking to lose stubborn weight.
What Is GLP-1?
We are excited to offer a GLP-1/B12 compounded agonist to help you take control of your life. GLP-1, or Glucagon-Like Peptide 1, is a hormone naturally produced in the body. Its primary function is to regulate blood sugar levels by stimulating insulin release from pancreatic beta cells and inhibiting glucagon secretion from pancreatic alpha cells. This action helps to lower blood glucose levels after a meal.3
GLP-1 also slows down the rate at which the stomach empties and promotes a feeling of fullness (satiety), which can help control appetite and food intake. Additionally, it has been found to inhibit glucagon secretion, reduce liver glucose production, and promote the growth and survival of pancreatic beta cells.
Due to its role in blood sugar regulation and potential for promoting weight loss, GLP-1 has become a target for the treatment of type 2 diabetes and obesity. Several medications known as GLP-1 receptor agonists have been developed to mimic the action of GLP-1 in the body. These medications are typically administered by injection and can help improve glycemic control, promote weight loss, and reduce the risk of cardiovascular events in people with type 2 diabetes.
Benefits of GLP-1
Along with helping to boost weight loss and control blood sugar, GLP-1 seems to have other significant benefits. Studies suggest certain medications in this category may reduce heart disease risk, encompassing heart failure, stroke, and kidney disease. Individuals on these medications have observed enhancements in blood pressure and cholesterol levels, though whether these stem directly from medication or weight loss remains uncertain.
How Much Weight Will I Lose With Weight Loss Injections?
The amount of weight loss you can expect with GLP-1 receptor agonists can vary depending on several factors, including your starting weight, individual metabolism, diet, exercise habits, and overall health. However, clinical studies have shown that GLP-1 receptor agonists can lead to significant weight loss in many individuals.
On average, people using GLP-1 receptor agonists typically experience weight loss ranging from 6% to 17% of their initial body weight over the course of several months to a year.4 Some individuals may experience even greater weight loss, while others may see more modest results.
It’s important to note that weight loss results can vary from person to person, and medication alone is usually not sufficient for achieving and maintaining weight loss. Lifestyle modifications such as adopting a healthy diet, increasing physical activity, and making long-term behavior changes are typically recommended alongside medication use to optimize weight loss outcomes and improve overall health.
Does GLP-1 Have Any Side Effects?
As with any medication, GLP-1 receptor agonists may cause side effects in some individuals. Common side effects include nausea, vomiting, diarrhea, and constipation.5 These symptoms often occur during the initial weeks of treatment and may improve over time as the body adjusts to the medication. GLP-1 receptor agonists have also been associated with hypoglycemia, especially when used in combination with other diabetes medications such as insulin or sulfonylureas, and may increase the risk of gallbladder-related problems, such as gallstones or inflammation of the gallbladder (cholecystitis).
It’s important to discuss any concerns or potential side effects with your Before-N-After provider before starting GLP-1 receptor agonist therapy. They can help determine if this type of medication is appropriate for you and monitor you for any adverse effects while you are taking it.
GLP-1 Injection Treatment Tiers
We offer a range of treatment tiers designed with you in mind. We know that every patient is unique and therefore each treatment plan is highly customizable. Each uses different doses of GLP-1 and falls into a range of costs between $80 – $120. These costs are weekly, as patients receive one injection per week.
- Slim Startup Program
- Slim Program
- Slim Plus Program
- Slim Extra Plus Program
- Slim Max Program
Candidates For GLP-1 Weight Loss Injections
In general, GLP-1 is intended for individuals looking to augment a healthy lifestyle with a weight loss medication that can accelerate weight loss. The GLP-1 class of drugs isn’t recommended if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasias as well as those who have an allergy to GLP-1 medications, a history of pancreatitis, are breastfeeding, or may be pregnant. In addition, patients already taking a GLP-1 or sulfonylurea mediation such as Dulaglutide (Trulicity), Semaglutide (Ozempic), Semaglutide (Rybelsus) should not take GLP-1.
Schedule A Consultation For Weight Loss Injections
If you’d like to learn more about weight loss injections at Before-N-After, please contact us today. We’d love to discuss your weight loss goals and customize a treatment plan designed to help you achieve them.
1 Gastroenterology & Hepatology. The Obesity Epidemic: Challenges, Health Initiatives, and Implications for Gastroenterologists. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033553/. Accessed June 14, 2022.
2 AHA Journals. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Available: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000973. Accessed June 14, 2022.
3 StatPearls. Glucagon-Like Peptide-1 Receptor Agonists. Available: https://www.ncbi.nlm.nih.gov/books/NBK551568/#. Accessed May 6, 2024.
4Advances in Therapy. Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063254/. Accessed May 6, 2024.
5 Journal of Clinical Medicine. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821052/#. Accessed May 6, 2024.
The Medical Professionals at Before-N-After have either authored or reviewed and approved this content.